Features of the use of synthetic analogues of thyroid hormones: а 2020 THESIS* questionnaire survey of members of the Belarusian Public Medical Association of Endocrinology and Metabolism

BACKGROUND. The standard treatment for hypothyroidism is levothyroxine (LT4), which in the Republic of Belarus is available in tablet form whereas liothyronine (LT3) is not registered, but patients can purchase them on their own abroad.

AIM. This study aimed to investigate Belarusian endocrinologists’ attitude of thyroid hormones in hypothyroid and euthyroid patients.

MATERIALS AND METHODS. An online survey was conducted, for which members of the Belarusian Medical Association of Endocrinology and Metabolism were invited by posting information in the group chat and by e-mail. The research period was from October 1 to December 26, 2020. 210 questionnaires were received, 146 of which were used.

RESULTS. The majority of participants, 145 (99.3%), indicated that they were using LT4 as the first-choice drug for the treatment hypothyroidism. Sixty-one (41.8%) doctors answered that LT3 + LT4 combination likely can be used in patients with long-term untreated hypothyroidism and 15 (10.3%) — in patients with persistent symptoms of hypothyroidism, despite biochemical euthyroidism on therapy LT4. Over half of the respondents 84 (57.5%) answered that thyroid hormone therapy was never indicated for euthyroid patients, but 50 (34.2%) would consider it for female infertility with high level of thyroid antibodies and 36 (24.7%) for simple goiter growing over time. In various conditions that could interfere with absorption of LT4, most responding Belarusian endocrinologists do not expect a significant difference with different formulations (tablets

+“I do not expect major changes in different forms” vs. “soft gel capsules”+“liquid solution”; p <0.001). Persistent symptoms of hypothyroidism on the background of LT4 replacement therapy with the achievement of the target TSH can mainly be caused by psychosocial factors, concomitant diseases, unrealistic patient expectations, chronic fatigue syndrome, and the burden of chronic disease.

CONCLUSION. The method of choice of Belarusian endocrinologists in the treatment of hypothyroidism is LT4 replacement therapy, but the appointment of LT4 + LT3 combination therapy can be considered in certain clinical situations. As a rule, endocrinologists do not prescribe LT4 in patients with euthyroidism and do not expect a significant difference when using other forms of levothyroxine.

1. Garmendia Madariaga A, Santos Palacios S, Guillén-Grima F, Galofré JC. The Incidence and Prevalence of Thyroid Dysfunction in Europe: A Meta-Analysis. J Clin Endocrinol Metab. 2014;99(3):923-931. https://doi.org/10.1210/jc.2013-2409

2. Fallahi P, Ferrari SM, Ruffilli I, et al. Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update. Expert Opin Drug Deliv. 2017;14(5):647-655. https://doi.org/10.1080/17425247.2016.1227782

3. Thvilum M, Brandt F, Almind D, et al. Type and Extent of Somatic Morbidity before and after the Diagnosis of Hypothyroidism. A Nationwide Register Study. PLoS One. 2013;8(9):1-6. https://doi.org/10.1371/journal.pone.0075789

4. Thvilum M, Brandt F, Almind D, et al. Increased psychiatric morbidity before and after the diagnosis of hypothyroidism: A nationwide register study. Thyroid. 2014;24(5):802-808. https://doi.org/10.1089/thy.2013.0555

5. Thvilum M, Brandt F, Brix TH, et al. Hypothyroidism is a predictor of disability pension and loss of labor market income: A Danish register-based study. J Clin Endocrinol Metab. 2014;99(9):3129-3135. https://doi.org/10.1210/jc.2014-1407

6. Thvilum M, Brandt F, Almind D, et al. Excess mortality in patients diagnosed with hypothyroidism: A nationwide cohort study of singletons and twins. J Clin Endocrinol Metab. 2013;98(3):1069-1075. https://doi.org/10.1210/jc.2012-3375

7. Heiberg Brix T, Ferløv-Schwensen C, Thvilum M, et al. Death by unnatural causes, mainly suicide, is increased in patients with Hashimoto’s thyroiditis. A nationwide Danish register study. Endocrine. 2019;65(3):616-622. https://doi.org/10.1007/s12020-019-01946-5

8. Winther KH, Cramon P, Watt T, et al. Disease-Specific as Well as Generic Quality of Life Is Widely Impacted in Autoimmune Hypothyroidism and Improves during the First Six Months of Levothyroxine Therapy. PLoS One. 2016;11(6):e0156925. https://doi.org/10.1371/journal.pone.0156925

9. Trimboli P, Scappaticcio L, De Bellis A, et al. Different Formulations of Levothyroxine for Treating Hypothyroidism: A Real-Life Study. Int J Endocrinol. 2020;2020:1-5. https://doi.org/10.1155/2020/4524759

10. Virili C, Trimboli P, Romanelli F, et al. Liquid and softgel levothyroxine use in clinical practice: state of the art. Endocrine. 2016;54:3-14. https://doi.org/10.1007/s12020-016-1035-1

11. Nagy EV, Perros P, Papini E, et al. New Formulations of Levothyroxine in the Treatment of Hypothyroidism: Trick or Treat? Thyroid. 2021;31(2):193-201. https://doi.org/10.1089/thy.2020.0515

12. Kraut E, Farahani P. A systematic review of clinical practice guidelines’ recommendations on levothyroxine therapy alone versus combination therapy (LT4 plus LT3) for hypothyroidism. Clin Invest Med. 2015;38(6):E305-313. https://doi.org/10.25011/cim.v38i6.26194

13. Jonklaas J, Bianco AC, Cappola AR, et al. Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document Thyroid. 2021;31(2):156-182. https://doi.org/10.1089/thy.2020.0720

14. Michaelsson LF, Medici BB, la Cour JL, et al. Treating Hypothyroidism with Thyroxine/Triiodothyronine Combination Therapy in Denmark: Following Guidelines of Following Trends? Eur Thyroid J. 2015;4:174-180. https://doi.org/10.1159/000437262

15. Peterson SJ, Cappola AR, Castro MR, et al. An online survey of hypothyroid patients demonstrates prominent dissatisfaction. Thyroid. 2018;28(6):707-721. doi: https://doi.org/10.1089/thy.2017.068

16. Vezzani S, Giannetta E, Altieri B, et al. An Italian survey of compliance with major guidelines for L-thyroxine of primary hypothyroidism. Endocr Pract. 2018;24(5):419-428. https://doi.org/10.4158/EP-2017-0159

17. Negro R, Attanasio R, Nagy EV, et al. Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients; the 2019 Italian Survey. Eur Thyroid J. 2020;9(1):25-31: https://doi.org/10.1159/000502057

18. Pearce SH, Brabant G, Duntas LH, et al. 2013 ETA Guideline Management of Subclinical Hypothyroidism. Eur Thyroid J. 2013;2(4):215-228. https://doi.org/10.1159/000356507

19. Рeterson SJ, McAninch EA, Bianco AC. Is a Normal TSH Synonymous With «Euthyroidism» in Levothyroxine Monotherapy? [published correction appears in J Clin Endocrinol Metab.2017;102(4):1406]. J Clin Endocrinol Metab. 2016;101(12):4964-4973 https://doi.org/10.1210/jc.2016-2660

20. Feller M, Snel M, Moutzouri E, et al. Association of Thyroid Hormone Therapy With Quality of Life and Thyroid-Related Symptoms in Patients With Subclinical Hypothyroidism: A Systematic Review and Meta-analysis. JAMA. 2018;320(13):1349-1359. https://doi.org/10.1001/jama.2018.13770

21. Klinicheskie rekomendatsii «Gipotireoz» Rossiiskoi assotsiatsii endokrinologov. Ed. by II. Dedov, GA. Mel’nichenko. Moscow; 2021. 34 p. (In Russ.).

22. Klinicheskii protokol po endokrinologii. Proekt. «Diagnostika i lechenie patsientov s zabolevaniyami shchitovidnoi zhelezy (vzrosloe naselenie)». (In Russ.). Доступно по: https://makaenka17med.by/respublikanskij-tsentr-endokrinologii/informatsiya-dlya-spetsialistov-endokrinologicheskoj-sluzhby/klinicheskie-protokoly-po-endokrinologii-vzrosloe-naselenie.